Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsBetty M. Tijms, Pieter Jelle Visser, Johan Gobom et al.|Brain|2020Cited by 221
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer DiseaseReisa A. Sperling, Gary Romano, David Henley et al.|JAMA Neurology|2021Cited by 110
Impaired Trunk Stability in Individuals at High Risk for Parkinson's DiseaseWalter Maetzler, Lorenzo Chiari, Martina Mancini et al.|PLoS ONE|2012Cited by 92
Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsManfred Gerlach, Daniela Berg, Walter Maetzler et al.|Journal of Neural Transmission|2011Cited by 73